| Literature DB >> 35087976 |
Salil Kumar Mandal1, Anwesha Maitra1, Purban Ganguly1, Stuti Somani Agarwal1.
Abstract
Aim: To evaluate the efficacy and usefulness of Tenzel rotational flap in upper and lower lid reconstruction in malignant tumors, to determine the anatomical alignment, functional, and cosmetic outcome after lid reconstruction and recurrence of the tumor and to observe the canthal and fornix status.Entities:
Keywords: lid; malignancy; reconstruction; rotational flap
Mesh:
Year: 2021 PMID: 35087976 PMCID: PMC8764431 DOI: 10.22336/rjo.2021.70
Source DB: PubMed Journal: Rom J Ophthalmol ISSN: 2457-4325
MRD-1 pre and postoperative, LPS action pre and post operative, central vertical palpebral fissure height, pre and post operative, created defect expressed in percentage, length of incision expressed in mm
| Sl. No. | MRD-1 Pre op. in mm | MRD-1 Post op. in mm after 6 months | LPS Action Pre op. in mm | LPS Action Post op. in mm after 6 months | Central Vertical fissure height in mm Pre op. | Central Vertical fissure height in mm after 6 months post op. | Created Defect in % | Length of incision in cm Convexity downwards in mm |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| 1. | +1 | 4 | 6 | 14 | 4 | 12 | 16÷30×100 =53.55% | 9 |
| 2. | -2 | 4 | 4 | 15 | 2 | 13 | 17÷30×100 =56.66% | 8 |
| 3. | -3 | 3.5 | 5 | 12 | 5 | 10 | 17÷30×100 =56.70% | 8.5 |
| 4. | -3 | 4.5 | 5 | 12 | 5 | 10 | 17÷30×100 =56.70% | 8.5 |
| 5. | +1 | 3.5 | 6 | 14 | 6 | 10.5 | 17÷30×100 =56.70% | 8.5 |
| 6. | -2 | 4 | 3 | 12 | 4 | 11 | 12÷30×100 =40% | 9 |
| 7. | -2 | 4 | 4 | 13 | 4 | 10 | 12÷30×100 =40% | 9.5 |
| 8. | -1 | 3.5 | 5 | 12 | 5 | 10.5 | 19÷30×100 =63.30% | 8.5 |
| 9. | -2 | 4 | 3 | 13 | 4 | 11 | 18÷30×100 =60% | 8.5 |
| 10. | -4 | 4 | 5 | 15 | 3 | 12 | 15÷30×100 =50% | 7 |
| 11. | -2 | 4 | 4 | 12 | 5 | 12 | 14÷30×100 =46.70% | 7.5 |
| 12. | 0 | 4 | 5 | 11 | 6 | 11 | 19÷30×100 =63.30% | 8.5 |
| 13. | -2 | 4 | 3 | 10 | 4 | 10 | 15÷30×100 =50% | 8 |
| 14. | +1 | 4 | 6 | 11 | 5 | 9 | 17÷30×100 =56.70% | 8.5 |
| 15. | 0 | 4 | 4 | 14 | 6 | 10 | 14÷30×100 =46.70% | 7.5 |
| 16. | +1 | 4.5 | 4 | 13 | 6 | 10.5 | 16÷30×100 =53.30% | 7.5 |
| 17. | +1 | 4 | 5 | 12 | 6 | 10 | 12÷30×100 =40% | 8 |
| 18. | 0 | 4.5 | 4 | 13 | 5 | 10.5 | 14÷30×100 =46.70% | 7.5 |
| 19. | -2 | 4 | 4 | 12 | 4 | 11 | 16÷30×100 =53.30% | 7.5 |
| 20. | -2 | 4.5 | 3 | 11 | 4 | 9 | 18÷30×100 =60% | 8.5 |
| 21. | 0 | 4 | 4 | 14 | 6 | 10 | 14÷30×100 =46.70% | 7.5 |
|
| ||||||||
| 22. | 3.5 | 4 | 14 | 14 | 12 | 12 | 20÷30×100 =66.66% | 10.5 |
| 23. | 3.5 | 4 | 12 | 12 | 8 | 10 | 16÷30×100 =53.30% | 10 |
| 24. | 3.5 | 4 | 13 | 13 | 7 | 11 | 16÷30×100 =53.30% | 9 |
| 25. | 4 | 4.5 | 12 | 12 | 8 | 10 | 17÷30×100 =56.70% | 8.5 |
| 26. | 3.5 | 4 | 13 | 13 | 8 | 10 | 16÷30×100 =53.30% | 9 |
| 27. | 4 | 4 | 12 | 12 | 8 | 11 | 18÷30×100 =60% | 10 |
| 28 | 3.5 | 4 | 10 | 12 | 9 | 10 | 13÷30×100 =43.30% | 8 |
| 29 | 4 | 4.5 | 10 | 12 | 8 | 11 | 14÷30×100 =46.70% | 8.5 |
| 30 | 3.5 | 3.3 | 10 | 10 | 8 | 10 | 19÷30×100 =63.3% | 10 |
|
|
Distribution of the diagnosis by FNAC of the specimen
| Sebaceous cell CA | 14 | 46.67% |
| Basal cell CA | 8 | 26.67% |
| Squamous cell CA | 2 | 6.67% |
| Infected epidermal cyst | 2 | 6.67% |
| Vascular lesion | 2 | 6.67% |
| Chalazion | 2 | 6.67% |
Distribution of histopathological diagnosis of the specimen
| HPE DIAGNOSIS | NUMBER (n=30) | PERCENTAGE% |
| Sebaceous cell CA | 17 | 56.67% |
| Basal cell CA | 8 | 26.67% |
| Squamous cell CA | 2 | 6.67% |
| Vascular tumor | 2 | 6.67% |
| Nodular hidradenoma | 1 | 3.33% |
| Chalazion | 0 | 0% |
Comparison of the diagnosis by FNAC and histopathology
| DIAGNOSIS | FNAC | HISTOPATHOLOGY |
| Sebaceous cell CA | 14 | 17 |
| Basal cell CA | 8 | 8 |
| Squamous cell CA | 2 | 2 |
| Vascular tumor | 2 | 2 |
| Infected epidermal cyst | 2 | 0 |
| Chalazion | 2 | 0 |
| Nodular hidradenoma | 0 | 1 |